Anti-CD3E重组抗体|科研级 Otelixizumab ( 奥昔组单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-CD3E重组抗体|科研级 Otelixizumab ( 奥昔组单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-CD3E重组抗体|科研级 Otelixizumab ( 奥昔组单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1152

Alias

科研级 Otelixizumab ( 奥昔组单抗 ), Anti-CD3E Recombinant Antibody, Research Grade Otelixizumab

Molecular Name

Otelixizumab

Size

￥500/100ug, ￥3200/1mg, ￥6800/5mg, 定制报价/10mg以上

CAS Number

881191-44-2

Isotype

IgG1 Lambda

Clonality

Monoclonal

Concentration

1mg/ml

Applications

FC, IP, ELISA, Neut, FuncS, IF, WB

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

CD3E[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases. The antibody is being developed by Tolerx, Inc. in collaboration with GlaxoSmithKline and is being manufactured by Abbott Laboratories.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用，不得用于人体或治疗用途。

靶点背景信息

实验方案&FAQ